Introduction 69 physiopathological events, such as regulation of vascular tone, neurotransmission, apoptosis, and 71 inflammation (Wink & Mitchell 1998) . NO is synthesized by nitric oxide synthases (NOS), a 72 family of enzymes catalyzing the conversion of L-arginine to L-citrulline and NO with a 1:1 73 stoichiometry (Nathan & Xie 1994). Three NOS isoforms have been described: endothelial 74 each time period considered, while at 0.1-1 μM it was not effective (Fig. 1A) . When the 131 spermatozoa were incubated with 10 µM GSNO, progressive motility (A + B classes) was 132 comparable to those of untreated sperm ( Fig 1A) . To check how long the effect of 5 µM GSNO 133 takes to develop, time-dependence experiments were performed. The increase of sperm motility 134 induced by GSNO was not significant at 10 and 20 minutes, but only after an at least 30 minutes 135 incubation ( Fig 1B) . Analyzing each class of motility we observed that the increase of 136 progressive motility (WHO classes A + B) after treatment with GSNO was mainly due to a 137 significant rise in the percentage of A class spermatozoa, which was counterbalanced by a 138 parallel decrease of both C and D class spermatozoa; the amount of spermatozoa exhibiting a B 139 pattern of motility did not change under all the experimental conditions (data not shown). On the 7 contrary, the motion parameters linearity (LIN) and straightness (STR) were unaffected, and no 141 induction of HA was observed (data not shown). 142
In the same way, GSNO strongly increased the individual parameters of sperm movement 143 straight linear velocity (VSL), curvilinear velocity (VCL) and average path velocity (VAP) when 144 added at 5 μM but not at 0.1-1 μM (data not shown). After the incubation with 10 µM GSNO, 145 VSL, VCL and VAP were comparable to those of untreated sperm, thus suggesting that GSNO at 146 this concentration was not yet toxic, but it neither could improve the sperm motility (data not 147 shown). Spermine NONOate (SPNO) is a faster NO donor than GSNO: when incubated with 148 several samples (n = 6) of spermatozoa, SPNO 0.5 µM significantly increased the progressive 149 motility (A + B classes) after 30 (71.2 + 2 % vs. 51 + 1 % in controls) and 60 min (69 + 3 % vs. 150 50 + 2 % in controls). In the same experimental conditions 0.5 µM SPNO increased significantly 151 also VSL, VCL and VAP (data not shown). 152
Oxidized glutathione (GSSG), the product of GSNO decomposition, is a powerful chelator of 153 copper ions (Singh et al. 1999 ). Since copper ions can influence the release of NO from GSNO, 154 we performed further experiments to check whether the increased sperm motility that we 155 observed after incubation with GSNO is due to the chelation of copper by GSSG. We measured 156 sperm motility in the presence of 5 µM reduced glutathione (GSH) or GSSG, to exclude that 157 glutathione per se, in any form, could alter the progressive motility: both GSH and GSSG had no 158 significant effect on sperm motility (n = 4; data not shown). To chelate copper we performed also 159 other experiments with 1 mM EDTA, and even in this case we did not observe any significant 160 modification vs. controls and vs. GSNO alone (n = 4; data not shown). After EDTA treatment the 161 level of calcium was about 1 mM. 162
Thereafter, the 5 μM concentration of GSNO was chosen to perform the subsequent 163 experiments. The NO donor induced a significant increase of sperm progressive motility 164 measured by CASA after incubation with freshly ejaculated human samples for 30, 60 and 90 165 min (Fig. 2) . The sGC inhibitor ODQ did not affect the progressive motility when added alone, 166 but completely blunted its GSNO-elicited increase at each time period ( Fig. 2 ). On the other 167 hand, 8-Br-cGMP, a cell-permeating cGMP analog, exerted a significant enhancing effect on 168 progressive motility per se and completely reversed the inhibitory effect of ODQ on the GSNO-169 stimulated increase (Fig. 2) . Finally, the PKG inhibitor Rp-8-Br-cGMPS, which per se did not 170 modify the sperm progressive motility, abolished the effects of GSNO and 8-Br-cGMP on this 171 motion parameter ( Fig. 2) . 172
In order to confirm the role of NO in this process, we measured also the progressive motility 173 in the presence of the NO scavenger PTIO. 100 µM PTIO did not affect sperm motility when 174 used alone, but when co-incubated with GSNO (5 µM) it completely reversed the increase of 175 motility induced by GSNO ( Fig. 3 ). In the presence of 20 μl of packed fresh red blood cells, used 176 as reservoirs of the NO scavenger oxyhemoglobin, the motility results were the same observed 177 with PTIO (n = 3; data not shown). To this purpose, we incubated the spermatozoa at the reported 178 concentrations used in the other experiments and for the indicated times (30, 60, 90 min) in the 179 lower compartment of a transwell system (having a polycarbonate transwell insert membrane 180 with pore sizes of 3 μm, in 24 well plates provided by Corning Incorporated, Apton, MA), 181 containing in the upper compartment 20 μl of packed fresh red blood cells in 0.5 ml of SWM. 182
After each incubation time the upper compartment was taken out and the sperm motility 183 parameters were measured as described in the Materials and Methods section. 184
We also evaluated the effect of NO on sperm kinetic parameters assessed by CASA. In the 185 presence of GSNO, the straight linear velocity (VSL) markedly increased, an effect that was 186 abolished by ODQ (which per se did not modify this motion parameter), as shown in Fig Since the measurement of intracellular cGMP was performed in the presence of the 203 phosphodiesterase inhibitor IBMX to inhibit cGMP hydrolysis, we performed further motility 204 experiments on samples pre-treated for 20 min with 200 µM IBMX and then for 30, 60 and 90 205 min with 5 µM GSNO: we observed that the pre-treatment with IBMX did not influence the 206 enhancement of sperm motility induced by NO ( Fig. 3) . Since the intracellular levels of cGMP measured after incubation with either GSNO or 8-Br-255 cGMP were respectively similar in both experimental works, in spite of the different incubation 256 times and concentrations used, it is likely that these compounds exert a significant effect on 257 sperm motility only when the level of intracellular cGMP is maintained increased for a time 258 longer than the one necessary for cGMP to modulate chemotaxis. This suggestion may make 259 sense, since it is reasonable to suppose that at a first time sperm needs to be simply oriented 260 versus a source of NO and only subsequently, when the increase of cGMP shows to be 261 persistently high, the motility should increase. 262
The effect of GSNO on sperm motility is indeed mediated by an increased synthesis of cGMP, 263 as the sGC inhibitor ODQ blunted the GSNO-elicited motility and abolished the increase of Subsequently, the samples were centrifuged at 13,000 g for 1 min, the supernatants were 357 discarded and 50 µl of absolute ethanol were added to the pellets; ethanol was then evaporated by 358 vacuum centrifugation, and 350 μl of Tris/EDTA buffer (50 mM Tris-HCl, 4 mM EDTA, pH 7.5) 359 were added. After 10 min, 100 μl of supernatant were tested for the cGMP level with a 360 [ 3 H]cGMP immunoassay system. The cGMP content was expressed as pmol/10 6 cells. Cross-361 reactivity of the [ 3 H]cGMP immunoassay system with cAMP was less than 0.001%. 362
Statistical analysis 363
All data are provided as means ± SEM. for 20 min, and subsequently they were incubated for 30, 60 or 90 min in the absence (CTRL) or 575 presence of the following substances, alone or in co-incubation: 5 μM GSNO, 10 μM ODQ, 500 576 μM 8-Br-cGMP. Then, intracellular cGMP concentration was determined as described under the 577 Materials and Methods section. The measurements were performed in triplicate, and data are 578 presented as means + SEM (n = 5). Significance vs. CTRL: * p < 0.001; vs. GSNO: ° p < 0.005; 579 vs. GSNO+ODQ: § p < 0.001. 580
